These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 26131374)
1. FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study. Marin Dos Santos DH; Atallah ÁN PeerJ; 2015; 3():e1015. PubMed ID: 26131374 [TBL] [Abstract][Full Text] [Related]
2. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. DeVito NJ; Bacon S; Goldacre B Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402 [TBL] [Abstract][Full Text] [Related]
3. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States. Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418 [TBL] [Abstract][Full Text] [Related]
4. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012. Miller JE; Korn D; Ross JS BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214 [TBL] [Abstract][Full Text] [Related]
5. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study. Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601 [TBL] [Abstract][Full Text] [Related]
6. Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA. Swanson MJ; Johnston JL; Ross JS Trials; 2021 Nov; 22(1):817. PubMed ID: 34789308 [TBL] [Abstract][Full Text] [Related]
7. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry. Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329 [TBL] [Abstract][Full Text] [Related]
9. Compliance with results reporting at ClinicalTrials.gov. Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355 [TBL] [Abstract][Full Text] [Related]
10. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting. Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112 [TBL] [Abstract][Full Text] [Related]
11. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. Prayle AP; Hurley MN; Smyth AR BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756 [TBL] [Abstract][Full Text] [Related]
12. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA. Talebi R; Redberg RF; Ross JS Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252 [TBL] [Abstract][Full Text] [Related]
13. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors. Hirsch L Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565 [TBL] [Abstract][Full Text] [Related]
14. Reporting Compliance and Factors Influencing Timeliness of Stroke-Related Trial Results on ClinicalTrials.gov. Cwajna M; Hamouda AM; Kendall N; Ghozy S; Elder BD; Kallmes DF Transl Stroke Res; 2024 Jun; ():. PubMed ID: 38831158 [TBL] [Abstract][Full Text] [Related]
15. Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis. Axson S; Mello MM; Lincow D; Yang C; Gross C; Ross JS; Miller J BMJ Open; 2021 Jul; 11(7):e053248. PubMed ID: 34281933 [TBL] [Abstract][Full Text] [Related]
16. Evaluating publication bias for clinical trials supporting new dermatologic drug approvals from 2003 to 2018. Ravichandran S; Mulligan KM; Ezaldein HH; Scott JF Arch Dermatol Res; 2023 May; 315(4):831-838. PubMed ID: 36333459 [TBL] [Abstract][Full Text] [Related]
17. ClinicalTrials.gov reporting: strategies for success at an academic health center. O'Reilly EK; Hassell NJ; Snyder DC; Natoli S; Liu I; Rimmler J; Amspacher V; Burnett BK; Parrish AB; Berglund JP; Stacy M Clin Transl Sci; 2015 Feb; 8(1):48-51. PubMed ID: 25387802 [TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
19. E-cigarette manufacturers' compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs. DeVito NJ; Drysdale H; McKee M; Goldacre B Tob Control; 2023 Jan; 32(1):60-66. PubMed ID: 34127550 [TBL] [Abstract][Full Text] [Related]
20. The project data sphere initiative: accelerating cancer research by sharing data. Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]